Statin use is associated with a decreasedrisk of all-cause mortalityamong patients with non-obstructivecoronary artery disease (CAD), accordingto a study published in Atherosclerosis(2015;239:335-342). 

The study included 8,372 patientswith non-obstructive CAD documentedby coronary computed tomographyangiography (CCTA). Of these, 1,983were prescribed statins (23.7%). Statinusers had a 60% decreased risk of all-causemortality and a 57% decreasedrisk of a composite endpoint of deathor late coronary revascularization (morethan 90 days after CCTA) comparedwith non-users, regardless of age, sex,presence of hypertension or diabetes,and other clinical factors.